乳腺癌术后内乳淋巴结转移患者的预后分析  

An analysis of prognosis in 16 breast cancer patients with postoperative internal mammary lymph node metastasis

作　　者：问静[1] 王丽君[1] 郭业松[1] 刘菊英[1] 黄蕾[1] 张倩[1] 姜雪松[1] 

机构地区：[1]江苏省肿瘤医院放疗科,210009

出　　处：《江苏医药》2016年第7期808-810,共3页Jiangsu Medical Journal

摘　　要：目的分析乳腺癌术后出现内乳淋巴结（IMLN）转移16例的预后。方法乳腺癌术后IMLN转移患者16例,10例行序贯化放疗,4例行化疗,2例行内分泌治疗。回顾性分析患者的临床特点及预后。结果随访3-77个月,随访期死亡12例,生存4例。16例患者中位生存期29.5个月,1、2和3年总生存率分别为87.5%、56.3%和41.7%。11例多发转移患者中位生存期20.0个月,1、2和3年生存率分别为81.8%、36.4%和18.2%。5例单发转移患者中,1例死亡,4例随访期无疾病进展。IMLN单发转移者预后较好。结论乳腺癌术后随访应重视IMLN状况;单发IMLN转移患者早发现、早治疗仍可获得较好预后。Objective To analyze the prognosis of 16 breast cancer patients with postoperative internal mammary lymph node（IMLN）metastasis.Methods Sixteen breast cancer patients were with postoperative IMLN metastasis,of whom 10 cases underwent sequential radiotherapy,4cases were treated with chemotherapy and 2cases were treated with endocrinotherapy.Results The patients were followed up for 3-77 months.Four cases were survival and 12 cases died during follow up.The overall survival time of 16 patients was 29.5 months,in whom one year,2-year and 3-year survival rates were 87.5%,56.3% and 41.7%,respectively.The overall survival time of 11 patients with multiple metastasis was 20.0 months,in whom one year,2-year and 3-year survival rates were81.8%,36.4% and 18.2%,respectively.The prognosis of 5 patients with single metastasis was better,of whom 4cases were survival with no disease progression and one case died.Conclusion An attention during follow up should be paid to the metastasis of IMLN in breast cancer patients after operation.A better prognosis can be achieved by early diagnosis and treatment in the patients with single IMLN metastasis.

关 键 词：乳腺癌 内乳淋巴结转移 

分 类 号：R737[医药卫生—肿瘤]